{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:12:14Z","timestamp":1791634334019,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Natural Science Foundation Project","award":["2025GXNSFAA069092"],"award-info":[{"award-number":["2025GXNSFAA069092"]}]},{"name":"Guangxi University Young and Middle-aged Teachers Scientific Research Basic Ability Enhancement Program","award":["2025KY0134"],"award-info":[{"award-number":["2025KY0134"]}]},{"name":"Guangxi University Young and Middle-aged Teachers Scientific Research Basic Ability Enhancement Program","award":["2024KY1774"],"award-info":[{"award-number":["2024KY1774"]}]},{"name":"Guangxi Higher Education Undergraduate Teaching Reform Project","award":["2024JGA154"],"award-info":[{"award-number":["2024JGA154"]}]},{"name":"Guangxi Key Laboratory of Precision Medicine in Cardio-cerebrovascular Diseases Control and Prevention","award":["22-035-18"],"award-info":[{"award-number":["22-035-18"]}]},{"name":"Guangxi Clinical Research Center for Cardio-cerebrovascular Diseases","award":["AD17129014"],"award-info":[{"award-number":["AD17129014"]}]},{"DOI":"10.13039\/501100009329","name":"Guangxi Science and technology planning project","doi-asserted-by":"crossref","award":["Guike AB24010178"],"award-info":[{"award-number":["Guike AB24010178"]}],"id":[{"id":"10.13039\/501100009329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31063-5","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T11:36:06Z","timestamp":1765366566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Overexpression of PRDX2 alleviates chronic thromboembolic pulmonary hypertension by modulating inflammation and mitophagy"],"prefix":"10.1038","volume":"16","author":[{"given":"Chen","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"31063_CR1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/rccm.202302-0327SO","volume":"208","author":"S Johnson","year":"2023","unstructured":"Johnson, S. et al. Pulmonary hypertension: A contemporary review. Am. J. Respir Crit. Care Med. 208, 528\u2013548 (2023).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"31063_CR2","doi-asserted-by":"crossref","unstructured":"Kovacs, G. et al. Definition, classification and diagnosis of pulmonary hypertension. Eur Respir J .64, 2401324(2024).","DOI":"10.1183\/13993003.01324-2024"},{"key":"31063_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.2023.24265","volume":"331","author":"RA Estrada","year":"2024","unstructured":"Estrada, R. A., Auger, W. R. & Sahay, S. Chronic thromboembolic pulmonary hypertension. Jama. 331, 972\u2013973 (2024).","journal-title":"Jama"},{"key":"31063_CR4","doi-asserted-by":"publisher","first-page":"1257988","DOI":"10.3389\/fimmu.2023.1257988","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Research progress of NF-\u03baB signaling pathway and thrombosis. Front. Immunol. 14, 1257988 (2023).","journal-title":"Front. Immunol."},{"key":"31063_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1164\/rccm.202109-2075OC","volume":"205","author":"XD Manz","year":"2022","unstructured":"Manz, X. D. et al. Epigenetic modification of the von Willebrand factor promoter drives platelet aggregation on the pulmonary endothelium in chronic thromboembolic pulmonary hypertension. Am. J. Respir Crit. Care Med. 205, 806\u2013818 (2022).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"31063_CR6","doi-asserted-by":"crossref","unstructured":"Smolders, V. et al. The inflammatory profile of CTEPH-Derived endothelial cells is a possible driver of disease progression. Cells. 10, 737(2021).","DOI":"10.3390\/cells10040737"},{"key":"31063_CR7","doi-asserted-by":"crossref","unstructured":"Yan, S., Sheak, J. R., Walker, B. R., Jernigan, N. L. & Resta, T. C. Contribution of mitochondrial reactive oxygen species to chronic Hypoxia-Induced pulmonary hypertension. Antioxidants (Basel). 12, 2060(2023).","DOI":"10.3390\/antiox12122060"},{"key":"31063_CR8","doi-asserted-by":"publisher","first-page":"eadk6524","DOI":"10.1126\/sciadv.adk6524","volume":"10","author":"AM Santamans","year":"2024","unstructured":"Santamans, A. M. et al. MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension. Sci. Adv. 10, eadk6524 (2024).","journal-title":"Sci. Adv."},{"key":"31063_CR9","doi-asserted-by":"crossref","unstructured":"Santos, E. W., Khatoon, S., Di Mise, A., Zheng, Y. M. & Wang, Y. X. Mitochondrial dynamics in pulmonary hypertension. Biomedicines.12, 53 (2023).","DOI":"10.3390\/biomedicines12010053"},{"key":"31063_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0168-8227(99)00037-6","volume":"45","author":"HZ Chae","year":"1999","unstructured":"Chae, H. Z., Kim, H. J., Kang, S. W. & Rhee, S. G. Characterization of three isoforms of mammalian Peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45, 101\u2013112 (1999).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"31063_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.freeradbiomed.2018.05.059","volume":"123","author":"SJ Park","year":"2018","unstructured":"Park, S. J., Kim, J. H., Lee, D. G., Kim, J. M. & Lee, D. S. Peroxiredoxin 2 deficiency accelerates age-related ovarian failure through the reactive oxygen species-mediated JNK pathway in mice. Free Radic Biol. Med. 123, 96\u2013106 (2018).","journal-title":"Free Radic Biol. Med."},{"key":"31063_CR12","doi-asserted-by":"publisher","first-page":"8359860","DOI":"10.1155\/2020\/8359860","volume":"2020","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Yang, S., Zhou, H. & Su, D. PRDX2 promotes the proliferation and metastasis of Non-Small cell lung cancer in vitro and in vivo. Biomed. Res. Int. 2020, 8359860 (2020).","journal-title":"Biomed. Res. Int."},{"key":"31063_CR13","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.neo.2018.08.013","volume":"20","author":"R Bera","year":"2018","unstructured":"Bera, R. et al. Genetic and epigenetic perturbations by DNMT3A-R882 mutants impaired apoptosis through augmentation of PRDX2 in myeloid leukemia cells. Neoplasia. 20, 1106\u20131120 (2018).","journal-title":"Neoplasia"},{"key":"31063_CR14","doi-asserted-by":"publisher","first-page":"e23168","DOI":"10.1016\/j.heliyon.2023.e23168","volume":"10","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Liu, J., Xiong, Z., Gu, S. & Xia, X. Exosome-derived miR-23a-5p inhibits HCC proliferation and angiogenesis by regulating PRDX2 expression: MiR-23a-5p\/PRDX2 axis in HCC progression. Heliyon.10, e23168 (2024).","journal-title":"Heliyon"},{"key":"31063_CR15","doi-asserted-by":"publisher","first-page":"113925","DOI":"10.1016\/j.yexcr.2024.113925","volume":"435","author":"X Zhan","year":"2024","unstructured":"Zhan, X. et al. MiR-92a-2-5p suppresses esophageal squamous cell carcinoma cell proliferation and invasion by targeting PRDX2. Exp. Cell. Res. 435, 113925 (2024).","journal-title":"Exp. Cell. Res."},{"key":"31063_CR16","doi-asserted-by":"publisher","first-page":"102066","DOI":"10.1016\/j.redox.2021.102066","volume":"46","author":"T Luo","year":"2021","unstructured":"Luo, T. et al. Thiol-disulphide independent in-cell trapping for the identification of Peroxiredoxin 2 interactors. Redox Biol. 46, 102066 (2021).","journal-title":"Redox Biol."},{"key":"31063_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jha2.660","volume":"4","author":"M Nagasawa","year":"2023","unstructured":"Nagasawa, M. Degradation of band3 and PRDX2 in erythrocytes during severe acute GVHD. EJHaem 4, 459\u2013462 (2023).","journal-title":"EJHaem"},{"key":"31063_CR18","doi-asserted-by":"publisher","first-page":"155080","DOI":"10.1016\/j.prp.2023.155080","volume":"254","author":"P Balasubramanian","year":"2024","unstructured":"Balasubramanian, P. et al. Implications and progression of Peroxiredoxin 2 (PRDX2) in various human diseases. Pathol. Res. Pract. 254, 155080 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"31063_CR19","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/tox.24153","volume":"39","author":"P Li","year":"2024","unstructured":"Li, P. et al. PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer. Environ. Toxicol. 39, 2869\u20132880 (2024).","journal-title":"Environ. Toxicol."},{"key":"31063_CR20","doi-asserted-by":"publisher","first-page":"7863","DOI":"10.1038\/s41598-024-58216-2","volume":"14","author":"A De Bol\u00f2s","year":"2024","unstructured":"De Bol\u00f2s, A. et al. SOX11\/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma. Sci. Rep. 14, 7863 (2024).","journal-title":"Sci. Rep."},{"key":"31063_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41419-021-03888-1","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53. Cell. Death Dis. 12, 605 (2021).","journal-title":"Cell. Death Dis."},{"key":"31063_CR22","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1038\/s41467-024-55013-3","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Neuronal PRDX-2-Mediated ROS signaling regulates food digestion via peripheral UPR(mt) activation. Nat. Commun. 15, 10582 (2024).","journal-title":"Nat. Commun."},{"key":"31063_CR23","doi-asserted-by":"publisher","first-page":"e926281","DOI":"10.12659\/MSM.926281","volume":"26","author":"H Li","year":"2020","unstructured":"Li, H., Yang, H., Wang, D., Zhang, L. & Ma, T. Peroxiredoxin2 (Prdx2) reduces oxidative stress and apoptosis of myocardial cells induced by acute myocardial infarction by inhibiting the TLR4\/Nuclear factor kappa B (NF-\u03baB) signaling pathway. Med. Sci. Monit. 26, e926281 (2020).","journal-title":"Med. Sci. Monit."},{"key":"31063_CR24","doi-asserted-by":"publisher","first-page":"3795320","DOI":"10.1155\/2019\/3795320","volume":"2019","author":"A Smukowska-Gorynia","year":"2019","unstructured":"Smukowska-Gorynia, A. et al. Prognostic value of oxidative stress markers in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension. Oxid. Med. Cell. Longev. 2019, 3795320 (2019).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"31063_CR25","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.123.067579","volume":"149","author":"Y Luo","year":"2024","unstructured":"Luo, Y. et al. Inactivation of malic enzyme 1 in endothelial cells alleviates pulmonary hypertension. Circulation.149, 1354\u20131371 (2024).","journal-title":"Circulation"},{"key":"31063_CR26","doi-asserted-by":"publisher","first-page":"e009768","DOI":"10.1161\/CIRCHEARTFAILURE.122.009768","volume":"16","author":"EA Mendiola","year":"2023","unstructured":"Mendiola, E. A. et al. Right ventricular architectural remodeling and functional adaptation in pulmonary hypertension. Circ. Heart Fail. 16, e009768 (2023).","journal-title":"Circ. Heart Fail."},{"key":"31063_CR27","doi-asserted-by":"crossref","unstructured":"Evans, C. E., Cober, N. D., Dai, Z., Stewart, D. J. & Zhao, Y. Y. Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J. 58, 2003957(2021).","DOI":"10.1183\/13993003.03957-2020"},{"key":"31063_CR28","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1161\/CIRCRESAHA.121.318225","volume":"128","author":"ME Colling","year":"2021","unstructured":"Colling, M. E., Tourdot, B. E. & Kanthi, Y. Inflammation, infection and venous thromboembolism. Circ. Res. 128, 2017\u20132036 (2021).","journal-title":"Circ. Res."},{"key":"31063_CR29","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/01.CIR.83.4.1371","volume":"83","author":"KM Moser","year":"1991","unstructured":"Moser, K. M. et al. Chronic pulmonary thromboembolism in dogs treated with Tranexamic acid. Circulation 83, 1371\u20131379 (1991).","journal-title":"Circulation"},{"key":"31063_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1183\/09031936.00081314","volume":"45","author":"J Guihaire","year":"2015","unstructured":"Guihaire, J. et al. Right ventricular reserve in a piglet model of chronic pulmonary hypertension. Eur. Respir J. 45, 709\u2013717 (2015).","journal-title":"Eur. Respir J."},{"key":"31063_CR31","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/ATVBAHA.122.317262","volume":"43","author":"R Quarck","year":"2023","unstructured":"Quarck, R. et al. Impairment of Angiogenesis-Driven clot resolution is a key event in the progression to chronic thromboembolic pulmonary hypertension: validation in a novel rabbit model. Arterioscler. Thromb. Vasc Biol. 43, 1308\u20131321 (2023).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"31063_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12931-016-0383-y","volume":"17","author":"C Deng","year":"2016","unstructured":"Deng, C. et al. The role of tissue factor and autophagy in pulmonary vascular remodeling in a rat model for chronic thromboembolic pulmonary hypertension. Respir Res. 17, 65 (2016).","journal-title":"Respir Res."},{"key":"31063_CR33","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ajpath.2016.12.004","volume":"187","author":"EM Neto-Neves","year":"2017","unstructured":"Neto-Neves, E. M. et al. Chronic embolic pulmonary hypertension caused by pulmonary embolism and vascular endothelial growth factor Inhibition. Am. J. Pathol. 187, 700\u2013712 (2017).","journal-title":"Am. J. Pathol."},{"key":"31063_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/HYPERTENSIONAHA.116.07247","volume":"67","author":"PA Arias-Loza","year":"2016","unstructured":"Arias-Loza, P. A. et al. Development and characterization of an inducible rat model of chronic thromboembolic pulmonary hypertension. Hypertension 67, 1000\u20131005 (2016).","journal-title":"Hypertension"},{"key":"31063_CR35","doi-asserted-by":"crossref","unstructured":"Karpov, A. A. et al. Model of chronic thromboembolic pulmonary hypertension in rats caused by repeated intravenous administration of partially biodegradable sodium alginate microspheres. Int J. Mol. Sci. 22, 1149 (2021).","DOI":"10.3390\/ijms22031149"},{"key":"31063_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature03587","volume":"435","author":"MH Choi","year":"2005","unstructured":"Choi, M. H. et al. Regulation of PDGF signalling and vascular remodelling by Peroxiredoxin II. Nature 435, 347\u2013353 (2005).","journal-title":"Nature"},{"key":"31063_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1161\/CIRCRESAHA.119.315259","volume":"126","author":"ML Bochenek","year":"2020","unstructured":"Bochenek, M. L. et al. Activated endothelial TGF\u03b21 signaling promotes venous thrombus nonresolution in mice via Endothelin-1: potential role for chronic thromboembolic pulmonary hypertension. Circ. Res. 126, 162\u2013181 (2020).","journal-title":"Circ. Res."},{"key":"31063_CR38","doi-asserted-by":"crossref","unstructured":"Ryanto, G. R. T., Suraya, R. & Nagano, T. Mitochondrial dysfunction in pulmonary hypertension. Antioxidants (Basel) .12, 372(2023).","DOI":"10.3390\/antiox12020372"},{"key":"31063_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41419-022-04906-6","volume":"13","author":"A Li","year":"2022","unstructured":"Li, A. et al. Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease. Cell. Death Dis. 13, 444 (2022).","journal-title":"Cell. Death Dis."},{"key":"31063_CR40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7150\/thno.80289","volume":"13","author":"N D\u2019Onofrio","year":"2023","unstructured":"D\u2019Onofrio, N. et al. SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells. Theranostics 13, 531\u2013542 (2023).","journal-title":"Theranostics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31063-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31063-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31063-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:03:09Z","timestamp":1768564989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31063-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31063"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31063-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods are reported in accordance with ARRIVE guidelines (\n                      \n                      ). Protocols involving human were approved by The Medical Ethics Committee of The First Affiliated Hospital of Guangxi Medical University(Nanning, China; approval no. 2024-S946-01). All animal procedures were approved by the Animal Ethics Committee of Guangxi Medical University and were conducted in accordance with the ethical guidelines for the use of experimental animals(Nanning, China; approval no. 202401001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"1589"}}